Bill Brown, Chairman of RUA Life Sciences, takes us through a presentation on the new structure following the name change from AorTech International, and the acquisition of RUA Medical. Looking at both the Medical, Vascular, Structural Heart, and Biomaterials divisions, he details the trial timelines and expected progress for their key products in the next 12 months.